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The Effect Of Pharmacist's Role On Patient Understanding And Satisfaction During 
The Provision of A Cost-Effective Pharmacist-led Intervention 
 
ABSTRACT 
 
Rationale, aims and objectives: The aim of this study is to identify the effect of pharmacist's 
role on patient understanding and satisfaction during the delivery of a cost-effective 
pharmacist-led intervention in asthma patients using partial least squares structural equation 
modelling (PLS-SEM).  
Methods: A validated questionnaire was used to gather patient views on a pharmacist-led 
intervention. A conceptual model was developed for testing 4 hypotheses. H1: What was the 
effect of patient understanding on patient satisfaction? H2: What was the effect of pharmacist 
role on patient understanding? H3: What was the effect of pharmacist role on patient 
satisfaction? H4: What were the in-sample and out-of-sample predictive power of the model? 
The study received ethics approval.  
Results: Two hundred forty-six patients returned the questionnaire. Construct reliability, 
validity, average extracted variance and discriminant validity were confirmed. The values of 
the path coefficients and effect sizes suggested that pharmacist's role played a significant part 
in the patient understanding, which then influenced patient satisfaction. The in-sample and out-
of-sample predictive powers were moderate. Patient's satisfaction is becoming an integral 
component in the health care provision and an element for the evaluation of the quality of 
health care. The results have demonstrated the need for further research assessing the link 
between pharmacist's role in patient's understanding and satisfaction when delivering cost-
effective pharmacist-led interventions. 
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Conclusions: This study highlighted the development and application of a simple conceptual 
model, using partial least squares structural equation modelling, for the evaluation of patients' 
satisfaction when receiving an effective and cost-effective pharmacist-led intervention.  
 
Keywords: Pharmacist, Intervention, Role, Patient, Understanding, Satisfaction 
 
INTRODUCTION 
Asthma is a chronic disease that affects adults and children all over the world  [1-3], and it is 
responsible for considerable global mortality and health-care costs  [4]. One in eight death in 
the European Union are from respiratory disease; 600,000 people die every day in the European 
Union from respiratory conditions. The total yearly cost of respiratory diseases in the EU 
exceeds 380 billion euros and the annual economic burden of asthma 72 billion  [5]. Many 
studies have advocated the role of pharmacists in asthma care, and although many well-
designed studies ([6-10] have been carried out in asthma; very few provided evidence of 
effectiveness  [11,12]. A large cluster randomised controlled trial conducted in Italy 
demonstrated the effectiveness and cost-effectiveness of the pharmacist-led intervention in 
asthma patients  [13], and further analysis showed that even the minimal importance different 
of the asthma control test (represented by a three-point shift in the ACT score) was cost-
effective  [14]. During this project, patients', pharmacists' and GPs' feedback was collected, 
and a report and a paper were published [15]. The analysis did not look specifically at the 
interaction amongst the pharmacist role, patient understanding and patient satisfaction during 
the provision of this bespoke pharmacist-led intervention. Structural equation modelling 
(SEM) represents a group of statistical techniques that have become very popular in business 
and social sciences, and its ability to model latent variables, to consider various forms of 
measurement error, and to evaluate entire theories makes it useful for a different type of 
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research [16]. SEMs can be divided into two groups: covariance-based (CB) and variance-
based (VB) SEM. Hair, et al., (2012) suggested that CB-SEM is a confirmatory approach that 
focuses on the model's theoretically established relationships and aims at minimising the 
difference between the model- implied covariance matrix and the sample covariance matrix 
[17]. In contrast, PLS-SEM is a prediction-oriented variance-based approach that focuses on 
endogenous target constructs in the model and aims at maximising their explained variance 
(for example looking at the coefficient of determination (R2) value) [17].CB-SEM estimates 
models parameters using empirical variance-covariance matrix, and it is the method of choice 
if the hypothesised model has one or more commons factors. VB-SEM first creates proxy as a 
linear combination of observed variables and then estimates the model parameters using these 
proxies. VB-SEM is the method of choice if the hypothesised contains composites. According 
to McDonald (1996) [18], amongst the VB-SEM methods, Partial Least Squares (PLS) path 
modelling is considered the most fully developed, and Hair et al. (2011) defined PLS-SEM 
the" Silver Bullet" [19]. PLS-SEM is widely used in different disciplines, such as information 
system research, strategic management [20], and marketing [21]. PLS-SEM has been used by 
Urbonas et al., (2015) to explore pharmacists' jobs satisfaction and the effects of different 
indicators on job satisfaction [22], and more recently by Murshid and Mohaidin (2019) to 
explore the influence of pharmacists' expertise on the prescribing decisions of physicians [23].  
Thus, the use of SEM is becoming popular in pharmacy practice research, and there are other 
studies published in this area  [24, 25]. In 2019, Manfrin et al.[26], used PLS-SEM to evaluate 
a conceptual model for students' satisfaction with team-based learning. Hannane et al., (2019) 
using SEM looked at asthma patients' perception of their care pathway [27]. Hindi et al., (2017) 
developed and validated the medicines use review patient satisfaction questionnaire [28]. This 
questionnaire was assessed using exploratory factor analysis and themes identified were: 1) 
perceptions of the MUR service itself, 2) pharmacist' delivery of the MUR service, 3) the 
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consultation room set, 4) and lack of awareness before having an MUR. This questionnaire 
presented some similarities to the one developed by Krska et al., (2009) which was used in our 
study [29]. To the best of our knowledge, PLS-SEM has not been used to evaluate the 
relationships among the role of the community pharmacist, patient understanding and patient 
satisfaction during the provision of a cost-effective pharmacist-led intervention. 
Aim 
To identify the effect of pharmacist's role on patients understanding and satisfaction during the 
provision of a bespoke, cost-effective pharmacist-led intervention using PLS-SEM. 
Conceptual Model 
Bollen in 2002 suggested that a path model is a diagram that displays the hypotheses and 
variable relationships estimated in an SEM analysis [30].  Sarstedt et al., (2017) said that the 
structural model represents the structural paths between the constructs (variables) [31], whereas 
the measurement models represent the relationships between each construct and its associated 
indicators. Sarstedt, et al., (2017) added that in PLS-SEM, structural and measurement models, 
are also referred to as inner and outer models [31]. For the evaluation of the path and predictors 
of patients' satisfaction, PLS-SEM was used, and a conceptual model designed. PLS-SEM can 
be used for casual predictive analysis but also for reflective and formative [32]. PLS-SEM is 
essentially a non-parametric method; therefore, the data do not need to be normally distributed. 
PLS-SEM handles the distribution from the data using bootstrapping to find out the statistical 
significance of the p values [33].  
In our study, we aimed at using PLS-SEM to show how patient satisfaction is influenced by 
pharmacist role and patient understanding and to find out the predictive power for patient 
satisfaction. The proposed model was analysed according to the flow chart developed by [31].  
The analysis of the model was conducted in different stages:  
1) The measurement model aimed at revealing the relationships between latent indicators 
 Andrea Manfrin   UCLan copyright 2020 
5 | P a g e  
 
and their variables; 
2) The structural model aimed at evaluating the relationships between the latent variables; 
3) PLS-SEM predict aimed at identifying the potential predictors for the latent variables.  
The conceptual model summarises four hypotheses (H) that this study was aiming to test after 
the provision of a bespoke effective and cost-effective pharmacist-led intervention for asthma 
patient (Figure 1).  
• Hypothesis 1 (H1): What was the effect of patient understanding on patient 
satisfaction? 
• Hypothesis 2 (H2): What was the effect of pharmacist role on patient understanding? 
• Hypothesis 3 (H3): What was the effect of pharmacist role on patient satisfaction? 
• Hypothesis 4 (H4): What were the in-sample and out-of-sample predictive power of 
the model?  
 
Figure I Conceptual model 
 
The arrows are connecting the circles, and the direction of the arrows represent the hypothesis that we were going 
to test. Dotted line refers to a potential less significant path, while solid lines refer to a potentially more significant 
path. 
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METHODS 
Study Design 
This is a methodological study. 
Population 
All the information regarding, the study setting, the selection process of the participants, 
inclusion and exclusion criteria and the validated questionnaire used for data collection are 
published elsewhere [34, 35] . 
Research Instrument 
The research instrument was a validated questionnaire aiming at gathering patient views on the 
medicine review service (pharmacist-led intervention) which had different types of questions, 
among which 5-point Likert Scale questions (strongly agree, agree, neutral, disagree, strongly 
disagree), which were selected and included in this study [34]. Their selection was based on a 
pragmatic approach regarding the possible relevance of each question to one of the three 
constructs (latent variables): pharmacist role (perceived by patients), patient understanding, 
patient satisfaction (Table I). 
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Table I Statements and latent variables 
Code Statements Latent variables 
Q11 The pharmacist put me at ease 
Pharmacist Role  
Q14 I felt that I was given enough time for the MUR 
Q15 I had the full attention of the pharmacist during the MUR 
Q17 The pharmacist wanted to help me deal with any concerns I had 
about my medication 
Q18 I felt comfortable asking any questions I had about my 
medication 
Patient Understanding  Q19 I understood everything discussed during the MUR 
Q27 I was given an opportunity to discuss any problems I had during 
the MUR 
Q20 I feel I benefited from having the MUR 
Patient Satisfaction 
Q24 I felt involved in all of the decisions made about my medications 
Q28 The MUR met my expectations 
Q29 I am happier with my medications after my review. 
 
Study Power 
The post hoc power of the study was estimated using G*Power version 3.1.9.3 A two tails t-
test was conducted using a multiple linear regression, with a fixed model and a single 
regression coefficient applying the following information: the number of patients enrolled in 
the study (n=246), the number of predictors (n=4), the effect size (f2=0.10), the probability of 
alpha error (0.05). The power of the study obtained was of 99.85%, with a degree of freedom 
of 241, a critical t=±1.97, and a non-centrality parameter 𝛿=4.95.  
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Data Collection and Cleaning 
Data were collected using a paper questionnaire, but because these data were part of a national 
project in which all the data were collected using an online platform (Qualtrics), for a matter 
of consistency, it was decided to import the data into the same platform. The data set was then 
exported and uploaded into SPSS version 21, for data cleaning.  
Selection Of The Appropriate Structural Equation Model  
Kolmogorov-Smirnov test was used for assessing normality. Data were not normally 
distributed, and a covariance-based structural equation model (CB-SEM) was not 
recommended according to [20]. Sarstedt et al.,  (2014) suggested that (VB-SEM) is a more 
robust approach than CB-SEM for handling non-parametric data [36]. Therefore, the SPSS 
data set was exported as a CVS file, and then uploaded onto SmartPLS (version 3.2.8), which 
is a variance-based structural equation model recommended for non-normally distributed data. 
Data Analysis 
The initial approach was to determine whether the model was formative or reflective and 
according to Gudergan et al., (2008) [37] and Bollen and Ting (2000) [38], the procedure of 
choice was confirmatory tetrad analysis (CAT). The implemented procedure needed at least 
four manifest variables (indicators) for each construct (latent variable). In our model, one of 
the constructs (patient understanding) had three manifest variables (indicators, Q18, Q19, 
Q20); therefore, it was decided to adopt a pragmatic approach applying a rule of thumb. If the 
indicators were interchangeable among themselves, the model was considered reflective, but 
if the indicators were not highly correlated and not interchangeable, the model was considered 
formative. The evaluation of the model was conducted using a reflective approach. 
The use of PLS-SEM allowed analysing the linear relationships between the latent constructs 
and the latent variables. Furthermore, PLS-SEM enabled testing several relationships instead 
of analysing each relationship individually. According to Henseler et al., (2009), PLS-SEM 
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consists of a two-step procedure involving the evaluation of the outer measurement model and 
the evaluation of the inner measurement model [39]. The statistical validity of the model was 
to assess using the bootstrapping procedure with a statistical significance of p<0.05. This 
procedure was repeated for 5000 samples. 
Evaluation Of The Outer Model  
An iterative algorithm with 300 iterations (PLS algorithm) was used to determine the reliability 
(outer loading coefficient), internal consistency, the validity of observed variables. Hair et al.,  
(2012) suggested that consistency evaluations are based on single observed and construct 
reliability test, while convergent and discriminant validity are used for the assessment of 
validity [20].The first step aimed at observing the variables loading coefficients; an outer 
loading coefficient, values ≥0.70 was recommended, but values of 0.40 or higher were 
considered acceptable for exploratory research, as in our case.  Furthermore, indicators with 
loading above 0.70 indicate that the construct explains over 50% of the indicator variance [40].  
The second step required the evaluation of the internal consistency and reliability using 
Cronbach's alpha ≥0.70 as the lower bound, composite reliability (CR≥0.70) using Dijkstra-
Henseler's rhoA (⍴A ) as the indicator of true reliability [41), and Dillon-Goldstein's rhoc (⍴c )  as 
the upper bound. These assumptions were suggested by Tenenhaus et al., (2005) [42] and Hair 
et al., (2017) [43]. Values of Cronbach's alpha and CR of at least 0.70 are required, although 
0.6 are The third step looked at the convergent validity, which measures the extent to which a 
construct converges in its indicators by explaining the items' variance [40].  The convergent 
validity was assessed using the average variance extracted (AVE) for all items associated with 
each construct. AVE was calculated as the mean of the squared loadings for all indicators 
associated with a construct. The value of AVE ≥0.50 indicates that on average, the construct 
explains over 50% of the variance of its items [44].   
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The fourth step was to assess the discriminant validity, which discriminates the extent to which 
a construct is empirically distinct from other constructs in the path model, in terms of 
correlation with other constructs and in term of how distinctively the indicators represent only 
single construct. The heterotrait-monotrait (HTMT) ratio of correlations is a new method for 
assessing discriminant validity in PLS-SEM and represents one of the key building blocks of 
model evaluation. According to the Henseler et al., (2014), if discriminant validity is not 
established, the researchers cannot be certain that the results confirming hypothesised structural 
paths are real, or whether they are merely the result of statistical discrepancies [45]. It seems 
that the HTMT criterion outperforms classic approaches to discriminant validity assessment 
such as Fornell-Larcker criterion and (partial) cross-loadings, which are largely unable to 
detect a lack of discriminant validity [45]. Henseler et al. (2014) argued that there are two ways 
of using HTM to assess discriminant validity: 1) as a criterion, 2) as a statistical test. The use 
of HTMT as a criterion implies that there is a predefined threshold, and if the value of HTMT 
is higher than the threshold than there is a lack of discriminant validity. The suggested threshold 
is 0.85 (HTMT.85) [45]. The second option is the use of HTMT based on its statistical 
discriminant validity test (HTMTinference). The use of the bootstrapping procedure allows for 
the construction of a confidence interval for HTMTinference. A confidence interval which 
contains the value of one is a sign of lack of discriminant validity. 
Evaluation Of The Inner Model 
Collinearity Among Constructs 
The collinearity among constructs represents the level of correlation between the two 
constructs. The variance inflation factor (VIF) is indicating the level of collinearity, for 
example, when two constructs are highly correlated. The VIF was assessed conducting a 
regression of each indicator on all other indicators in the same measurement model. The critical 
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value of VIF is >5, but when is >3 it requires cautions as well. Therefore, low VIF values (<3) 
represent good values [19, 46]. 
Predictive Relevance Of The Model 
Two types of predictions were generated and analysed: in-sample and out-of-sample 
prediction. 
In-sample Predictive Power 
The "in sample" prediction was conducted analysing the coefficient of determination (R2) and 
the effect size (f2). This analysis provides the explanatory power, using the data set to estimate 
the model and predict observation from this data set. The value of R2 measures the variance 
that is explained in each endogenous construct, and for this reason, it represents the "in sample 
predicting power" (explanatory power) [47, 48]. R2 values range from 0 to 1, they depend on 
the discipline, but as rule of thumb R2 ≈0.25 is regarded as weak, R2 ≈0.50 moderate, R2 ≈0.75 
strong predictive power respectively [19, 39]. Furthermore, R is a function of the number of 
predictor constructs, and the higher is the number of predictors the higher is R2 [46]. The effect 
size (f2) assesses how strongly one exogenous construct contributes to explaining a certain 
endogenous construct in terms of R2. According to Cohen (1988), the effect size is regarded as 
weak (0.02≤f2≤0.15), moderate (0.15≤f2≤0.35), strong (f2≥0.35), respectively [49].  
Out-of-sample Predictive Power 
The procedure was conducted for assessing the predictive power, which allows the model 
estimates to predict new observation (e.g. future observation). For this analysis, the predictive 
relevance, also known as predictive power (Q2), was used.    The value of Q2 could be within 
different ranges, weak (0.02≤ Q2≤0.15), moderate (0.15≤ Q2≤0.35), strong (Q2≥0.35) 
predictive power, respectively. Two main procedures can be followed for the calculation of Q2, 
the first is blindfolding, and the second is PLSpredict. Sarstedt et al., (2017) suggested that the 
value of Q2 using blindfolding does not produce a true measure of out-of-sample prediction as 
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blindfolding does not omit entire observations but only data points [31]. If the obtained Q2 
values are >0, they are meaningful. Therefore, this value of Q2 can only be partly considered a 
measure of out-of-sample prediction because the sample structure remains largely intact in its 
computation [31]. Shamueli et al., (2016) introduced a new approach for out-of-sample 
prediction, which is now embedded into SmartPLS under the function PLSpredict [50].  
PLSpredict rests on the principle of K-fold cross-validation. The procedure splits the data set 
into K equal parts (K=10 in our case) and estimate the model K-times on K-1 data sets using r 
as the number of repetition (r=10 in our case because it is a good trade-off between accuracy 
and running time). In this case if Q2 >0, it means that the model (PLS) outperforms the naivest 
benchmark represented by the linear model (LM). Furthermore, an important indication of the 
predictive power is represented by the comparison between the root mean squared error 
(RMSE) of prediction values obtained with PLSpredict versus the RMSE values obtained with 
(LM). If the PLS yields higher prediction errors than the LM model in terms of RMSE for all 
values this means no predictive power, the majority (low predictive power), the minority or the 
same (medium predictive power) none of the indicators (high predictive power). Therefore, in 
our study, we adopted PLSpredict. All the results were deemed to be statistically significant 
with p-value<0.05. 
Invitation Letter 
Italian community pharmacists contacted all their patients (895) who received the pharmacist-
led intervention (medicines use review (MUR)) service and invited them to complete a paper 
questionnaire. An invitation and an information letter were given to patients, explaining what 
was requested. Patients were asked to bring back the questionnaire in a sealed envelope to the 
pharmacy to ensure pharmacists did not see responses; the pharmacists then collected all the 
questionnaires and posted them to Medway School of Pharmacy for analysis using individually 
sealed envelopes. 
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Ethics Approval 
Ethical approval was obtained from the Faculty (University of Kent) Research Ethics 
Committee (ref. No 024S12/13), as the Principal Investigator's (Andrea Manfrin) base. The 
study participants were patients who received the MUR service. Return of the questionnaire to 
the pharmacist implied consent for its use in the evaluation. 
Data Storage/Confidentiality/Anonymity 
 In terms of data storage, contact sheets and consent forms containing personal information 
have been filed in a secure cabinet separate to any other participant data collected, to which 
only the research team could have access. Data obtained from the mail questionnaire have been 
coded and stored electronically on a computer system in a directory which is password 
protected. All electronic data have been password protected and accessible only by the 
researcher. All data were treated following requirements of the Data Protection Act (1998); 
they have been anonymised and stripped of any identifiable references to the participants.  
RESULTS 
Population Demographics 
Table 2 presents the demographic profile of the respondents, which is showing the frequency 
and the percentage of patients who replied to each statement. Two-hundred and forty-six 
patients provided information giving a response rate of 27.5% (246/895); only one patient 
failed to identify the location of residence. One patient did not select the gender, leaving 245 
valid cases; patients’ gender was represented by 56.7% (n=139) female and 43.3% (n=106) 
male. Two-hundred and forty-four patients selected their age and two cases were missing. 
Patients' ethnicity was recorded by 244 people leaving only two missing cases. The patient 
population was heavily represented by white, 98.4% (n= 240), 1.2% (3) classified themselves 
as mixed and 0.4% (n=1) as black. Nearly one patient out of two (44.9%) completed the 
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primary and few years of secondary school, only eight patients did not go to school, and only 
three cases were missing.  
Table II Demographic profile of the respondent patients 
Patients characteristics Number (%) 
Place of residence 
Brescia 76 (31.0) 
Pistoia 68 (27.8) 
Treviso 63 (25.7) 
Torino 38 (15.5) 
 (Missing 1) 
Gender 
Male 106 (43.3) 
Female 139 (56.7) 
 (Missing 1)  
Age 
18-30 20 (8.2) 
31-40 20 (8.2) 
41-50 26 (10.7) 
51-60 48 (19.7) 
61-70 51 (20.9) 
71-80 58 (23.8) 
>80 21 (8.5) 
 (Missing 2)  
Ethnicity 
White 240 (98.4) 
Black 1 (0.4) 
Mixed 3 (1.2) 
 (Missing 2)  
Education 
Primary/few years of secondary 109 (44.9) 
Secondary completed 73 (30.0) 
Bachelor degree 26 (10.7) 
College / further education 20 (8.2) 
None 8 (3.3) 
Still studying 4 (1.6) 
Higher degree 3 (1.2) 
 
(Missing 3)  
Percentages were calculated on the number of responses 
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Figure I Path model generated using the PLS algorithm  
 
The values inside the circles represent the coefficient of determination (R2). The values overlapping the arrows 
pointing towards the rectangles represent the outer loading coefficients. The values overlapping the arrows 
between the circles (constructs) represent the path coefficients (standardised beta=beta coefficients).  
 
Outer Model 
Reliability And Validity 
All the values presented in Table 3 have shown that the model has either construct reliability 
and validity. Only three out of 11 loading coefficients were just below 0.70 (Q11, Q20 and 
Q24). Cronbach's alpha, ⍴A, ⍴C and AVE were all above the recommended thresholds.  
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Table III Construct reliability and validity 
Main Constructs Items 
Loadings 
(≥0.70) 
CA 
(>0.70) 
⍴A 
( 0>70) 
⍴C 
(>0.70) 
AVE 
(>0.50) 
Pharmacist Role  
Q11 0.697 
0.784 0.794 0.860 0.607 
Q14 0.799 
Q15 0.843 
Q17 0.770 
Patient Understanding  
Q18 0.841 
0.727 0.731 0.846 0.647 Q19 0.806 
Q27 0.764 
Patient Satisfaction 
Q20 0.651 
0.727 0.794 0.833 0.558 
Q24 0.692 
Q28 0.860 
Q29 0.768 
CA: Cronbach's alpha; ⍴A: construct reliability measure (true reliability); Composite reliability:  ⍴A and ⍴C; 
AVE: average variance extracted 
 
Discriminant Validity 
The more conservative approach (HTMT85) showed that all three HTMT values were <0.85 
(Table 3). The HTMTinference was calculated with the bootstrap routine, also using the bias-
corrected and accelerated bootstrap (Bca) procedure with a 95% confidence interval. All the 
upper limits of the confidence intervals were lower than 1 (Table IV). The HTMT values were 
within the recommended thresholds; therefore, discriminant validity was achieved. 
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Table IV Discriminant validity  
Constructs HTMT 
95%  
CI 
95% BCa  
CI 
Patient Understanding- Patient 
Satisfaction 
0.813 (0.683;0.935) (0672;0.925) 
Pharmacist Role-Patient 
Satisfaction 
0.674 (0.540;0.801) (0.532;0.793) 
Pharmacist Role- Patient 
Understanding 
0.846 (0.757;0.929) (0.753;0.926) 
HTMT: Heterotrait-monotrait ratio of correlation; CI: Confidence interval; BCa: Bias-corrected and accelerated 
bootstrap 
 
The results presented in table 3 and 4 confirmed that the measurements of the reflective model 
were valid and reliable. 
Inner Model  
Collinearity Among Constructs 
The analysis of the collinearity among constructs showed that the variance inflation factor 
(VIF) between patient understanding and patient satisfaction was 1.73, pharmacist role and 
patient satisfaction 1.73 and pharmacist role and patient understanding 1.00. All the VIF values 
were well <3; the model did not present collinearity issues. 
In-sample Prediction 
Significance, Relevance And Effect Size Of Path Coefficients 
All three path coefficients were positive and statistically significant, the higher was linked with 
H2, and the lower with H3 (Table V). The effect sizes were statistically significant and strong 
for H2 (f2=0.730; 95% CI 0.498;1.101; p<0.001), moderate for H1 (f2=0.222; 95% CI 
0.099;0.436; p=0.012); the effect size was weak and non-statistically significant for H3 
(f2=0.051 95% CI 0.003;0.159; p=0.210). The direct effect of pharmacist role on patient 
satisfaction was 0.227 (a relationship linking two constructs with a single arrow between the 
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two). The indirect effect 0.308 (95% CI 0.204;0.432; p<0.001) (a sequence if relationships with 
a least one intervening construct involved). The total effect 0.535 (95% CI 0.433;0.632; 
p<0.001) (the sum of the direct effect and all the indirect effects linking two constructs). 
In-sample Predictive Power 
The R2 value for patient understanding was slightly higher than the one for patient 
satisfaction, but both coefficients were statistically significant. Furthermore, the model 
showed a moderate in-sample predictive power (Table VI). 
Out-of-sample Predictive Power 
The predictive power (Q2) values of the PLS analysis were >0 indicating that the model 
outperforms the most naïve benchmark (e.g. the indicator means from the analysis sample) of 
the linear model (LM). The analysis compared the root mean squared error (RMSE) generated 
by PLSpredict with the RMSE of a linear model (LM). Four out of seven RMSE values (Q18, 
Q28, Q24, Q29) were lower in the PLSpredict model, and one was equal to the linear model 
(LM) (Q19), and three were higher. The results suggested that this model has a medium out-
of-sample predictive power (Table VII). 
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Table V Significance and relevance of the path coefficients (standardised beta) 
Hypothesised Path Standardised Beta t-value 
95%  
CI 
95% BCa  
CI 
p-value 
  
Effect size 
(f2) 
Patient Understanding- Patient 
Satisfaction (H1) 
0.474 6.017 (0.326;0.630) (0.304;0.614) <0.001 
 
 
0.222 
 
Pharmacist Role- Patient 
Understanding (H2) 
0.650 17.354 (0.577;0.724) (0.563;0.714) <0.001 
 
0.730 
Pharmacist Role-Patient 
Satisfaction (H3) 
0.227 2.730 (0.059;0.384) (0.062;0.387) 0.006 
 
 
0.051 
 
CI: Confidence interval; BCa: Bias -corrected and accelerated bootstrap; t-value (t-statistics) thresholds: ±1.97 
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Table VI Coefficients of determination (R2) 
Main Construct 
Coefficient of 
Determination (R2) 
t-value 
95% 
 CI 
95% BCa  
CI 
p-value 
Patient Satisfaction 0.416 7.657 (0.323;0.536) (0.300;0.512) <0.001 
Patient Understanding 0.422 8.657 (0.333;0.524) (0.317;0.509) <0.001 
Bca: Bias -corrected and accelerated bootstrap; T-value (T Statistics) thresholds: ±1.97 
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Table VII Out of sample predictive power  
Code Statements RMSE (PLS) Q2 (PLS) RMSE (LM) 
 
Q2 (LM) 
Q18 
I felt comfortable asking any questions I had about 
my medication 
0.498 0.353 0.507 
 
0.330 
Q28 The MUR met my expectations 0.607 0.250 0.615 
 
0.229 
 
Q27 
I was given an opportunity to discuss any problems I 
had during the MUR 
0.625 0.228 0.622 
 
0.235 
Q19 I understood everything discussed during the MUR 0.656 0.210 0.656 
 
0.209 
Q29 I am happier with my medications after my review 0.703 0.180 0.708 
 
0.167 
Q20 I feel I benefited from having the MUR 0.825 0.107 0.821 
 
0.115 
Q24 
I felt involved in all of the decisions made about my 
medications 
0.862 0.051 0.866 
 
0.041 
Predictive power according to Q2: 0.02≤Q2<0.15 (Weak); 0.15≤Q2<0.35 (Moderate); ≥0.35 (Strong); RMSE: Root Mean Squared Error; PLS: Partial Least Squares 
LM: Linear Model 
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DISCUSSION 
The number of patients who participated in this study was 246, 57% were female, 43% male. 
A conceptual model was designed aiming to test and evaluate four hypotheses; three (H1, H2, 
H3) were related to the path coefficients and one (H4) to the in-sample and out-of-sample 
predicting power of the model. Three constructs (latent variables) were included in the model, 
pharmacist role, patient understanding and patient satisfaction. One construct (patient 
understanding) had less than four manifest variables (indicators), and for this reason, it was not 
possible to conduct a confirmatory tetrad analysis for assessing the nature of each construct, 
whether formative or reflective. Thus, a pragmatic approach was adopted using a reflective 
model for the assessment of the outer model and inner model structure. A positive path 
coefficient was found for each hypothesis, suggesting that patient understanding had a positive 
influence on patient satisfaction (H1), pharmacist role had a positive effect on patient 
understanding (H2) and patient satisfaction (H3). In our model, the largest path coefficient was 
between pharmacist role and patient understanding (0.650) the smallest was between 
pharmacist role and patient satisfaction (0.227) suggesting that patient satisfaction was driven 
by patient understanding. The higher effect size (f2) was for pharmacist role and patient 
understanding and the smallest for pharmacist role and patient satisfaction, suggesting that the 
pharmacists played a major part in patient understanding. Manfrin and Krska (2018) conducted 
a study with a large number of patients (n=1711) comparing the number and type of 
pharmaceutical care issues (PCI) that pharmacists identified in two different studies using the 
same pharmacist-led intervention and found that patient education was the most popular [35]. 
A PCI is defined as an element of pharmaceutical need which is addressed by the pharmacist 
[51, 52]. Patient education is a PCI which represents the need that the patient has to understand; 
similar results were found in other studies conducted in Denmark [53], and Germany  [54]. 
Wang et al., (2019) explored the pathways to outpatients' satisfaction with health care in 
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Chinese public hospitals using a PLS model [55]. In this study, the patients' experience of 
professional competence was strongly related to their satisfaction. In our study, pharmacists' 
role had a direct positive influence on patient understanding which was positively linked to 
patient satisfaction as well. Amankwah et al., (2019) looked at modelling the mediating effect 
of health care healing environment on core health care delivery and patient satisfaction in 
Ghana [56]. The data were analysed using SmartPLS, and the procedure was similar to the one 
used in our study; they assessed the in-sample predictive power, but not the out-of-sample. 
Their finding confirmed that the health care healing environment mediated patient satisfaction. 
A study conducted in Qatar which aimed at measuring patients' satisfaction with 
pharmaceutical services at a public hospital, established, with statistical evidence, that patient 
satisfaction was positively influenced by pharmacist attitude and medication counselling [57]. 
Another study, conducted in Turkey used SEM and looked at factors affecting patient 
satisfaction, suggested that persons with a higher level of education were less satisfied when 
compared to those with a lower level of education [58]. In our study, we did not perform this 
comparison, but it is important to recognise that the level of education could have a relevant 
impact on patient perception and satisfaction as well. In the study conducted in Qatar and 
Turkey, the authors used CB-SEM but did not provide justifications for their choice. In our 
study, we justified the rationale for using of PLS-SEM. 
Strengths and Limitations 
This study was aiming at assessing the effect of the pharmacist's role on patient understanding 
and patient satisfaction. To the best of our knowledge, this is the first attempt to evaluate these 
three dimensions after the provision of an effective and cost-effective pharmacists-led 
intervention in asthma patients using PLS-SEM. The conceptual model was simple but robust, 
showing the effect of pharmacist's role on the patient's understanding and satisfaction. This 
study has some limitations, such as the selection of the questions which was based on a 
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pragmatic approach, the number of manifested variables that for one construct was three and 
for this reason, it was not possible to perform a confirmatory tetrad analysis for assessing either 
the formative or reflective nature of each construct.  
Conclusion 
It has been suggested that patient satisfaction is becoming an integral component in the health 
care provision and an element for the evaluation of the quality of health care [59]. The authors 
added that patient satisfaction is used and will be used in the future for performance assessment 
and reimbursement. Furthermore, it has been suggested that patient satisfaction could be a 
predictor of health-related behaviour [59].  
In our study, the role that pharmacists played has demonstrated the positive impact on patient 
understanding which has driven patient satisfaction in our model. Our results have uncovered 
the needs to conduct further studies assessing the link between the role of the pharmacist, 
patient's understanding and satisfaction when delivering effective and cost-effective 
pharmacist-led intervention using larger samples and different conditions in primary and 
secondary care.  
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